"Designing Growth Strategies is in our DNA"

Platelet Rich Plasma Market Size, Share And Global Trend By Origin (Allogeneic, Autologous, Homologous), By Type (Pure PRP, Leukocyte rich PRP, Leukocyte rich fibrin), By Application (Orthopaedic surgery, Cosmetic surgery, General surgery, Neurosurgery, Others), And Geography Forecast Till 2030

Region : Global | Report ID: FBI100581 | Status : Ongoing

 

KEY MARKET INSIGHTS

Platelets are blood cells that help the body to form blood clots to halt bleeding and generated in the bone marrow along with white and red blood cells. Microscopic view of the platelets is like a tiny plate. A normal count of platelet is 150,000 to 450,000 platelets per microliter of blood. Platelet rich plasma (PRP), is a composed of high concentration of platelet rich plasma protein acquired from whole blood and centrifuged to differentiate between plasma and blood cells. PRP has several uses such as tissue healing, hair growth, inflammation reduction and others.


Rise in the use of platelet rich plasma for the treatment of chronic diseases such as orthopaedic diseases, cardiovascular & neurovascular diseases, general surgery, wound management and the increase in demand of the cosmetic surgeries is expected to drive the growth of the global PRP market. Growing geriatric population, increase in the occurrence of orthopaedic and sports injuries, combined with rising adoption of PRP as effective treatment option is one of the factors expanding the growth of the global PRP market.


To gain extensive insights into the market, Request for Customization


However, poor quality control of test results, high cost of the PRP kits, nerve injuries to the patients and tissue damage at the time of treatment are some of the major factors restraining the growth of the global PRP market.


Key Players Covered


Some of the major companies that are present in the global platelet rich plasma market are Arthrex, Inc., Zimmer Biomet, Harvest Technologies Corporation, DePuy Synthes, Inc., Stryker Corporation, AdiStem Ltd., ISTO Biologics, Cesca Therapeutics, Inc., Exactech Inc., Nuo Therapeutics and others.


SEGMENTATION


























SEGMENTATION



 DETAILS



By Origin



·      Allogeneic


·      Autologous


·      Homologous



By Type



·      Pure PRP


·      Leukocyte rich PRP


·      Leukocyte rich fibrin



By Application



·      Orthopaedic surgery


·      Cosmetic surgery


·      General surgery


·      Neurosurgery


·      Others



By Geography



·      North America (USA and Canada)


·      Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)


·      Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)


·      Latin America (Brazil, Mexico and Rest of Latin America)


·      Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)



                       


Among the segmentation of application, the orthopaedic surgery is estimated to hold a major proportion in the global PRP market owing to the high prevalence of the disease.


Key Insights


Pipeline analysis


Pricing analysis


Key mergers and acquisitions


Technological advancements


Regional Analysis


The global PRP market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. North America is projected to hold the highest position in the global PRP market due to a rise in the demand for cosmetic surgeries, high prevalence of orthopaedic surgeries and an increase in sports injuries. According to Arthritis Foundation, in North America 54 million adults and around 300,000 children were diagnosed of arthritis in 2017, this has increased the demand of the PRP treatment is further anticipated to fuel the growth of the global PRP market. Asia Pacific is projected to expand the global PRP market at significant CAGR in the forecast period due to the large patient pool with various rheumatology disorders, rise in a number of sport injury cases and increase in demand of cosmetic surgeries in emerging countries such as India and China.


Key Industry Developments



  • In July 2017, Regenexx completed the acquisition of Harbor View Medical Services.

  • In May 2019, Estar Technologies Ltd. announced that the European Patent Office has revoked the patent of Regen Lab SA’s Platelet Rich Plasma (PRP) patent due to lack of novelty.

  • In February 2014, ThermoGenesis Corp. received stockholder approval for acquisition of TotipotentRX Cell Therapy Pvt. Ltd.

  • In September 2016, Alliance Partners, LLC received 510(k) approval from the U.S Food and Drug Administration for the company’s Cyclone Platelet Rich Plasma (PRP) Concentrating System


  • Ongoing
  • 2022
  • 2019-2021

    CHOOSE LICENSE TYPE

  • $4850
    $5850
    $7850

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

abbvie
Grifols
Styker
uniliver
Amgen

Client Testimonials

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X